Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2024 Filed Feb 23, 2024 18:08 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantOptions · Derivative | 5,257 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004177 · form4.xml · derivative · entry 10 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,257 Underlying: Humana Common · 5,257 shares Expires 2031-02-21 F7 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F7 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 18:08 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantHumana Common | 1,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004177 · form4.xml · nonDerivative · entry 3 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,248 F11 · shares: Restricted stock units granted to reporting person on 2/21/24. F12 · balance_after: Includes 1,362 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:54 UTC |
Ventura Joseph CChief Legal Officer
|
GrantOptions · Derivative | 6,572 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004170 · form4.xml · derivative · entry 9 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,572 Underlying: Humana Common · 6,572 shares Expires 2031-02-21 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:54 UTC |
Ventura Joseph CChief Legal Officer
|
GrantHumana Common | 4,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004170 · form4.xml · nonDerivative · entry 3 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,453 F10 · shares: Restricted stock units granted to reporting person 2/21/24. F11 · balance_after: Includes 4,425 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:52 UTC |
Huval Timothy S.Chief Administrative Officer
|
GrantOptions · Derivative | 6,309 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004168 · form4.xml · derivative · entry 9 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,309 Underlying: Humana Common · 6,309 shares Expires 2031-02-21 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:52 UTC |
Huval Timothy S.Chief Administrative Officer
|
GrantHumana Common | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004168 · form4.xml · nonDerivative · entry 3 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,747 F10 · shares: Restricted stock units granted to reporting person on 2/21/24. F11 · balance_after: Includes 4,357 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:09 UTC |
Diamond Susan MChief Financial Officer
|
GrantOptions · Derivative | 9,989 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004158 · form4.xml · derivative · entry 9 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,989 Underlying: Humana Common · 9,989 shares Expires 2031-02-21 F6 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F6 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:09 UTC |
Diamond Susan MChief Financial Officer
|
GrantHumana Common | 13,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004158 · form4.xml · nonDerivative · entry 3 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,791 F11 · shares: Restricted stock units granted to reporting person on 2/21/24. F12 · balance_after: Includes 13,480 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:07 UTC |
Dintenfass DavidPresident, Enterprise Growth
|
GrantOptions · Derivative | 51,389 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004156 · form4.xml · derivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,389 Underlying: Humana Common · 51,389 shares Expires 2031-02-21 F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 17:07 UTC |
Dintenfass DavidPresident, Enterprise Growth
|
GrantHumana Common | 13,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004156 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,310 F2 · shares: Restricted stock units granted to reporting person on 2/21/24. F3 · balance_after: Includes 13,310 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 16:53 UTC |
Renaudin George IIPresident, Medicare & Medicaid
|
GrantOptions · Derivative | 6,966 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004154 · form4.xml · derivative · entry 6 Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,966 Underlying: Humana Common · 6,966 shares Expires 2031-02-21 F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 16:53 UTC |
Renaudin George IIPresident, Medicare & Medicaid
|
GrantHumana Common | 7,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004154 · form4.xml · nonDerivative · entry 3 Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,623 F9 · shares: Restricted stock units granted to reporting person on 2/21/24. F10 · balance_after: Includes 7,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 16:13 UTC |
Shetty Sanjay KPresident, CenterWell
|
GrantOptions · Derivative | 6,572 | $0.00 Strike: $367.21 | $0.00 |
DisclosureSEC source: 0001062993-24-004149 · form4.xml · derivative · entry 3 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,572 Underlying: Humana Common · 6,572 shares Expires 2031-02-21 F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 16:13 UTC |
Shetty Sanjay KPresident, CenterWell
|
GrantHumana Common | 7,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004149 · form4.xml · nonDerivative · entry 1 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,317 F5 · shares: Restricted stock units granted to reporting person on 2/21/24. F6 · balance_after: Includes 7,148 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 15:37 UTC |
Mesquita Jorge S.Director
|
PurchaseHumana Common | 545 | $367.09 | $200,066.07 |
DisclosureSEC source: 0001062993-24-003797 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,578 F3 · price: Shares acquired through open-market purchase at reported weighted average price. F1 · balance_after: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:05 UTC |
Rechtin James A.President & COO
|
GrantRestricted Stock Units · Derivative | 6,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000737 · form4.xml · derivative · entry 3 Rechtin James A. · CIK 0002006065 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,548 Underlying: Humana Common · 6,548 shares Expires not disclosed F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:05 UTC |
Rechtin James A.President & COO
|
GrantOptions · Derivative | 29,230 | $0.00 Strike: $458.19 | $0.00 |
DisclosureSEC source: 0001062993-24-000737 · form4.xml · derivative · entry 2 Rechtin James A. · CIK 0002006065 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,230 Underlying: Humana Common · 29,230 shares Expires 2031-01-08 F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 1/8/2024, vesting in three annual increments from 1/8/25 to 1/8/27. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:46 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000218 · form4.xml · derivative · entry 4 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:45 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000216 · form4.xml · derivative · entry 4 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 21:20 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000192 · form4.xml · derivative · entry 5 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 17:19 UTC |
SMITH BRAD DDirector
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000136 · form4.xml · derivative · entry 5 SMITH BRAD D · CIK 0001284323 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 17:17 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000134 · form4.xml · derivative · entry 5 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:45 UTC |
Mesquita Jorge S.Director
|
GrantHumana Common | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000130 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,033 F1 · balance_after: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 430 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting 12/31/24. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:22 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000128 · form4.xml · derivative · entry 5 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:20 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000126 · form4.xml · derivative · entry 4 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:03 UTC |
Garratt John WDirector
|
GrantHumana Common | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000120 · form4.xml · nonDerivative · entry 1 Garratt John W · CIK 0001646121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,685 F3 · balance_after: Includes 430 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/2024. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 15:12 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000110 · form4.xml · derivative · entry 5 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 14:56 UTC |
DAMELIO FRANK ADirector
|
GrantRestricted Stock Units · Derivative | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000108 · form4.xml · derivative · entry 5 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430 Underlying: Humana Common · 430 shares Expires not disclosed F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:46 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 9 | $456.91 | $4,112.22 |
DisclosureSEC source: 0001062993-24-000218 · form4.xml · derivative · entry 3 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15 Underlying: Humana Common · 9 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:45 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 6 | $456.91 | $2,741.48 |
DisclosureSEC source: 0001062993-24-000216 · form4.xml · derivative · entry 3 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8 Underlying: Humana Common · 6 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:20 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 3 | $456.91 | $1,370.74 |
DisclosureSEC source: 0001062993-24-000192 · form4.xml · derivative · entry 4 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3 Underlying: Humana Common · 3 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:20 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 40 | $456.91 | $18,276.53 |
DisclosureSEC source: 0001062993-24-000192 · form4.xml · derivative · entry 3 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141 Underlying: Humana Common · 40 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:19 UTC |
SMITH BRAD DDirector
|
GrantRestricted Stock Units · Derivative | 3 | $456.91 | $1,370.74 |
DisclosureSEC source: 0001062993-24-000136 · form4.xml · derivative · entry 4 SMITH BRAD D · CIK 0001284323 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3 Underlying: Humana Common · 3 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:19 UTC |
SMITH BRAD DDirector
|
GrantRestricted Stock Units · Derivative | 71 | $456.91 | $32,440.84 |
DisclosureSEC source: 0001062993-24-000136 · form4.xml · derivative · entry 3 SMITH BRAD D · CIK 0001284323 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262 Underlying: Humana Common · 71 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:17 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 211 | $456.91 | $96,408.69 |
DisclosureSEC source: 0001062993-24-000134 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,816 Underlying: Humana Common · 211 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:17 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 304 | $456.91 | $138,901.61 |
DisclosureSEC source: 0001062993-24-000134 · form4.xml · derivative · entry 3 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,188 Underlying: Humana Common · 304 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 16:22 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 257 | $456.91 | $117,426.69 |
DisclosureSEC source: 0001062993-24-000128 · form4.xml · derivative · entry 4 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,123 Underlying: Humana Common · 257 shares Expires not disclosed F4 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F4 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F4 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F4 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 16:20 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 9 | $456.91 | $4,112.22 |
DisclosureSEC source: 0001062993-24-000126 · form4.xml · derivative · entry 3 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15 Underlying: Humana Common · 9 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 16:03 UTC |
Garratt John WDirector
|
GrantRestricted Stock Units · Derivative | 2 | $456.91 | $913.83 |
DisclosureSEC source: 0001062993-24-000120 · form4.xml · derivative · entry 3 Garratt John W · CIK 0001646121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2 Underlying: Humana Common · 2 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 15:12 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 17 | $456.91 | $7,767.52 |
DisclosureSEC source: 0001062993-24-000110 · form4.xml · derivative · entry 4 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37 Underlying: Humana Common · 17 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · derivative · entry 15 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,176 Underlying: Humana Common · 588 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · derivative · entry 14 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512 Underlying: Humana Common · 512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · derivative · entry 12 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 367 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 274 | $463.58 | $127,020.92 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 6 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,080 F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 5 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 239 | $463.58 | $110,795.62 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 4 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,766 F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 3 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 171 | $463.58 | $79,272.18 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,493 F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:08 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022817 · form4.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 16:00 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022815 · form4.xml · derivative · entry 13 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670 Underlying: Humana Common · 334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.